Medical Developments International Limited
MDDVF
$0.3206
-$0.187-36.84%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 6.51M | 6.70M | 5.95M | 5.94M | 4.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.51M | 6.70M | 5.95M | 5.94M | 4.91M |
| Cost of Revenue | 1.72M | 1.76M | 1.55M | 1.55M | 1.33M |
| Gross Profit | 4.80M | 4.93M | 4.40M | 4.39M | 3.59M |
| SG&A Expenses | 3.92M | 4.03M | 4.66M | 4.65M | 6.92M |
| Depreciation & Amortization | 520.30K | 535.00K | 615.50K | 614.20K | 497.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.15M | 6.33M | 6.82M | 6.81M | 8.75M |
| Operating Income | 359.10K | 369.20K | -868.90K | -867.10K | -3.83M |
| Income Before Tax | 103.30K | 106.20K | -6.64M | -6.62M | -4.17M |
| Income Tax Expenses | 4.20K | 4.40K | 3.26M | 3.26M | -599.20K |
| Earnings from Continuing Operations | 99.00K | 101.80K | -9.90M | -9.88M | -3.57M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 99.00K | 101.80K | -9.90M | -9.88M | -3.57M |
| EBIT | 359.10K | 369.20K | -868.90K | -867.10K | -3.83M |
| EBITDA | 879.40K | 904.20K | -814.80K | -813.20K | -3.33M |
| EPS Basic | 0.00 | 0.00 | -0.11 | -0.11 | -0.04 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.03 |
| EPS Diluted | 0.00 | 0.00 | -0.11 | -0.11 | -0.04 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.03 |
| Average Basic Shares Outstanding | 107.37M | 107.37M | 86.31M | 86.31M | 86.31M |
| Average Diluted Shares Outstanding | 112.58M | 112.58M | 86.31M | 86.31M | 86.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |